Ophthalmology
Top Medical News

Jairia Dela Cruz,
Yesterday
For people with type 2 diabetes (T2D) and diabetic retinopathy (DR), bariatric surgery does not appear to confer any risk of DR progression, according to a study.

3 days ago
Normal-tension glaucoma (NTG) patients with hypertension who experience morning blood pressure (BP) surge are likely to have visual field progression, as shown in a study.

Stephen Padilla,
5 days ago
Use of calcium-channel blockers (CCBs) appears to increase the risk of developing glaucoma, suggests a study. In addition, use of systemic beta blockers is associated with lower intraocular pressure (IOP).

Kanas Chan,
6 days ago
Myopia prevalence in school-age children has reached record high in Hong Kong and may remain high over the next few years, a cross-sectional study by researchers from the Chinese University of Hong Kong (CUHK) has found.

24 Sep 2023
For patients who undergo adalimumab tapering after achieving remission, factors such as age, race, and duration of disease remission on adalimumab appear to impact the risk of relapse, according to a study.

Jairia Dela Cruz,
15 Sep 2023
The use of calcium channel blockers (CCBs) may contribute to an increased risk of glaucoma despite CCBs having no effect on intraocular pressure (IOP), according to a large study.

11 Sep 2023
Among teens and young adults, users of both e-cigarettes and cigarettes are more likely to experience severe and frequent ocular symptoms than abstainers, as reported in a study.
Special Reports

June Chiang, Ph.D,
26 May 2022
A new algorithm objectively determines when intraocular lens implant (IOL) surgery should be performed, regardless of how the opacity looks to the surgeon.

Roshini Claire Anthony,
28 Jun 2020
Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.
Conference Reports

Elvira Manzano,
23 May 2023
Artificial intelligence (AI) can help diagnose thyroid eye disease (TED) and assess for severity by analysing CT scans, reports an expert at ARVO 2023.

Elvira Manzano,
11 May 2023
Switching from other anti-VEGF* agents to brolucizumab only helps improve visual acuity and reduces disease activity in patients with neovascular (wet) age-related macular degeneration (nAMD)